Search Results (166)

Lipid-polymer hybrid nanoparticles (LPHNPs) are the next-generation nanocarriers that integrate the mechanical strength and sustained-release capacity of polymeric cores with the biocompatibility and high drug-loading efficiency of lipid shells. Various design strategies and architectures that enhance encapsulation efficiency, stability, and targeted delivery of diverse therapeutic agents are reviewed. Commonly employed polymers, lipids, and surfactants that enable controlled drug release and enhanced pharmacokinetic performance are summarized in tabular form, while fabrication methods such as single-step, emulsification-solvent evaporation, and microfluidic techniques are discussed for their scalability and reproducibility. The therapeutic potential of LPHNPs in delivering poorly soluble drugs, phytochemicals, and genetic materials achieving synergistic therapeutic outcomes in oncological applications is comprehensively highlighted. The manuscript also includes details on ligand-based functionalization and the integration of imaging and stimuli-responsive elements to enhance targeted delivery and develop multifunctional theranostic LPHNPs systems. Furthermore, non-oncologic applications of LPHNPs in ocular, topical, and oral delivery are discussed, emphasizing their potential in treating inflammatory, infectious, and autoimmune disorders with sustained release and enhanced therapeutic efficacy. Recent patents focusing on improved biocompatibility, dual-drug encapsulation, and mRNA delivery are summarized. However, challenges such as large-scale production, reproducibility, safety, and regulatory standardization must be addressed through quality by design approaches and advanced manufacturing technologies to fully realize the clinical and commercial potential of next-generation LPHNPs. Full article

The integration of polymer coatings with metal and metal oxide nanoparticles represents a significant advancement in nanotechnology, enhancing the stability, biocompatibility, and functional versatility of these materials. These enhanced properties make polymer-coated nanoparticles key components in a wide range of applications, including biomedicine, catalysis, environmental remediation, electronics, and energy storage. The unique combination of polymeric materials with metal and metal oxide cores results in hybrid structures with superior performance characteristics, making them highly desirable for various technological innovations. Polymer-coated metal and metal oxide nanoparticles can be synthesized through various methods, such as grafting to, grafting from, grafting through, in situ techniques, and layer-by-layer assembly, each offering distinct control over nanoparticle size, shape, and surface functionality. The distinctive contribution of this review lies in its systematic comparison of polymer-coating synthesis approaches for different metal and metal oxide nanoparticles, revealing how variations in polymer architecture and surface chemistry govern their stability, functionality, and application performance. The aim of this paper is to provide a comprehensive overview of the current state of research on polymer-coated nanoparticles, including metals such as gold, silver, copper, platinum, and palladium, as well as metal oxides like iron oxide, titanium dioxide, zinc oxide, and aluminum oxide. This review highlights their design strategies, synthesis methods, characterization approaches, and diverse emerging applications, including biomedicine (e.g., targeted drug delivery, gene delivery, bone tissue regeneration, imaging, antimicrobials, and therapeutic interventions), environmental remediation (e.g., antibacterials and sensors), catalysis, electronics, and energy conversion. Full article

Hydrogel films have emerged as versatile platforms in biomedical engineering due to their unique physicochemical properties, biocompatibility, and adaptability to diverse therapeutic needs. This review provides a comprehensive overview of hydrogel film materials, including natural biopolymers, synthetic polymers, and multifunctional composites, highlighting their structural and functional diversity. We examine key fabrication techniques—ranging from solvent casting and photopolymerization to advanced methods like microfluidics and 3D printing—and discuss how these influence film architecture and performance. The biomedical applications of hydrogel films span wound healing, drug delivery, tissue engineering, ophthalmology, and implantable biosensors, with recent innovations enabling stimuli-responsive behavior, multi-drug loading, and integration with wearable electronics. Despite their promise, hydrogel films face persistent challenges in mechanical durability, sterilization, storage stability, regulatory approval, and scalable manufacturing. We conclude by identifying critical research gaps and outlining future directions, including AI-guided design, sustainable material development, and the establishment of standardized, regulatory-aligned, and industrially scalable fabrication strategies to accelerate clinical translation. Full article

Sexually transmitted infections, notably herpes simplex virus, remain significant global health concerns. Localized delivery systems that provide sustained antiviral activity at mucosal surfaces offer an attractive alternative to systemic therapies. In this study, we developed electrohydrodynamically deposited coatings utilizing a covalent acyclovir–poly (lactic-co-glycolic acid) (ACV–PLGA) conjugate for potential antiviral functionalization of medical devices. The ACV–PLGA prodrug was synthesized via drug-initiated ring-opening polymerization, yielding a copolymer characterized by FTIR, NMR, GPC, and DSC, with controlled drug loading and biodegradable properties. Systematic optimization of electrospinning and electrospraying parameters enabled the fabrication of both particulate and nanofibrous coatings on silicone ring models. Morphological analysis by SEM demonstrated that polymer concentration, solvent composition, and applied voltage critically governed coating architecture, ranging from microparticle layers to uniform bead-free fibers. In vitro studies revealed morphology-dependent degradation profiles and sustained release of ACV over 56 days. This integrated approach combining covalent prodrug synthesis with tunable electrohydrodynamic deposition offers a promising strategy for long-acting local antiviral prophylaxis via functionalized medical surfaces. Full article

Polymeric micelles are widely studied as nanocarriers for hydrophobic drugs, yet their structural stability under physiological conditions remains a major limitation. This review provides a comparative evaluation of synthetic and natural polymeric micelles with a focus on their stability under dilution and in protein-rich environments. The discussion integrates thermodynamic and kinetic factors governing micelle integrity and examines how molecular composition, hydrophobic segment length, and core–shell modifications influence disintegration behavior. While synthetic micelles commonly collapse below their critical micelle concentration during intravenous administration, natural polymeric micelles, such as those derived from chitosan, alginate, or heparin, exhibit improved resistance to dilution but remain vulnerable to protein-induced destabilization. Strategies such as core or shell cross-linking, surface functionalization, and natural polymer coatings are reviewed as promising approaches to enhance circulation stability and controlled drug release. The work provides a framework for designing micellar systems with balanced biocompatibility, biodegradability, and robustness suitable for clinical drug-delivery applications. Full article

This study offers an integrated synthesis of polymeric materials in biomedical engineering, revealing four major and interlinked research domains: tissue engineering and regenerative medicine, drug delivery and nanomedicine, wound healing and antimicrobial applications, and advanced fabrication through 3D/4D printing and bioprinting. Across these areas, hydrogels, biodegradable composites, and stimuli-responsive polymers emerge as the most influential material classes. The analysis highlights substantial progress in extracellular matrix–mimetic scaffolds, smart drug delivery systems with controlled release, multifunctional wound dressings integrating antimicrobial and healing functions, and patient-specific constructs produced via additive manufacturing. Despite these advances, recurring challenges persist in long-term biocompatibility and safety, scalable and reproducible fabrication, and regulatory standardisation. The results point toward a convergence of bioactivity, manufacturability, and clinical translation, with hybrid natural–synthetic systems and personalised polymeric designs defining the next phase of biomedical polymer innovation. Full article

Background/Objectives: Despite the advantages of polycaprolactone (PCL) for drug delivery, it still lacks effective approaches to enhance its encapsulation of drugs. Blending PCL with less hydrophobic polymers can tailor physicochemical properties to overcome these limitations. This study, for the first time, integrates two beneficial approaches—polymer blending and Box–Behnken design (BBD) optimisation—to develop PCL-based blend nanoparticles (NPs) with enhanced encapsulation efficiency (EE), controlled particle size, and improved stability through surface charge modulation. Methods: Drug-loaded blend NPs were developed using a double emulsion method, with different polymer ratios. A BBD model was employed to investigate the influential factors that control the size, charge, and EE. Results: Blending PCL with a less hydrophobic polymer significantly improved EE, achieving 60.96% under optimal conditions. The BBD model successfully predicted conditions for obtaining NPs with optimum size, negative charge, and enhanced drug encapsulation. The drug amount was identified as the most influential factor for EE, while polymer amounts significantly impacted size and charge. Conclusions: Careful control of polymer ratios, drug amount, and surfactant levels was shown to significantly influence particle size, surface charge, and EE, with the balanced 50:50 PCL:PLGA blend achieving optimal physicochemical performance. Using the BBD, the study identified the predicted optimal formulation consisting of 162 mg polymer blend, 8.37 mg drug, and 8% surfactant, which is expected to yield NPs with a size of 283.06 nm, zeta potential of −31.54 mV, and EE of 70%. The application of BBD allowed systematic evaluation of the factors and their interactions, providing robust predictive models. Full article

Hydrogel/electrospun polymer nanofiber composites (HENC) integrate the advantages of both components. Hydrogels provide high water content, biocompatibility, and tunable drug release, while electrospun nanofibers offer a high surface area, loading capacity, customizable morphology, and opportunities for functionalization. Nanofibers can also be incorporated into hydrogels as 3D-printable inks. Together, these features create biomimetic composites that modulate drug release and mimic native tissues. This article reviews electrospinning fundamentals, limitations, preparation methods for HENC, and their applications in drug delivery, as well as future perspectives for developing advanced functional materials with improved therapeutic efficacy, controlled release kinetics, and broad biomedical adaptability. Full article

Hydrogels are hydrophilic biocompatible polymers that can be used as a drug delivery material in different medical branches, including vital pulp therapy. The aim of this study is to characterize the physical and biological properties of the newly developed formula as a candidate direct pulp-capping material. The hydrogel composite was prepared from natural and synthetic origins (polyvinyl alcohol (PVA), hyaluronic acid (HA), and sodium alginate (SA)) with the incorporation of bioactive Moringa. Different formulas of hydrogel containing different concentrations were evaluated for physicochemical (FTIR, XRD, SEM, degradation, and swelling), mechanical (viscosity, folding endurance, film thickness), and biological (antioxidant, antibacterial, and cytotoxicity) properties. FTIR and XRD confirmed successful incorporation and partial cross-linking between moringa and hydrogel compounds. At low concentrations of moringa, the hydrogel formula showed integrity, scavenging activity, and homogeneity. The moringa-loaded films showed concentration-dependent antioxidant and antibacterial properties, especially at higher concentrations, with acceptable cytocompatibility. The low concentration of moringa (0.5%) may be considered a promising candidate as a novel pulp-capping agent supporting tissue healing and regeneration. Full article

Background: Sustained-release (SR) formulations of non-steroidal anti-inflammatory drugs (NSAIDs) aim to prolong therapeutic activity, reduce dosing frequency, and improve patient adherence. However, currently marketed SR NSAIDs exhibit persistent limitations, including incomplete control over release kinetics, high interpatient variability in bioavailability, limited reduction in gastrointestinal adverse effects, and insufficient dose flexibility for individualized therapy. In many cases, conventional excipients and release mechanisms remain predominant, leaving drug-specific physicochemical and pharmacokinetic constraints only partially addressed. These gaps highlight the need for a comprehensive synthesis of recent technological advances to guide the development of more effective, patient-centered delivery systems. Methods: A narrative literature review was conducted using Web of Science and PubMed databases to identify original research articles and comprehensive technological studies on oral SR formulations of NSAIDs and paracetamol published between January 2020 and March 2025. Inclusion criteria focused on preclinical and technological research addressing formulation design, excipient innovations, and manufacturing approaches. Results: Sixty-four studies met the inclusion criteria, encompassing polymeric matrices (31%), lipid-based carriers (18%), microspheres/hydrogel beads/interpenetrating polymer networks (30%), nanostructured systems (11%), and hybrid platforms (10%). The most common strategies involved pH-dependent release, mucoadhesive systems, and floating drug delivery, aiming to optimize release kinetics, minimize mucosal irritation, and sustain therapeutic plasma levels. Advances in manufacturing—such as hot-melt extrusion, 3D printing, electrospinning, and spray drying—enabled enhanced control of drug release profiles, improved stability, and in some cases up to 30–50% prolongation of release time or reduction in Cmax fluctuations compared with conventional formulations. Conclusions: Recent formulation strategies show substantial potential to overcome long-standing limitations of SR NSAID delivery, with expected benefits for patient compliance and quality of life through reduced dosing frequency, better tolerability, and more predictable therapeutic effects. Nevertheless, integration of in vitro performance with pharmacokinetic and clinical safety outcomes remains limited, and the translation to clinical practice is still in its early stages. This review provides a comprehensive overview of current technological trends, identifies persisting gaps, and proposes future research directions to advance SR NSAID systems toward safer, more effective, and patient-focused therapy. Full article

Biopolymers have emerged as a transformative class of materials that reconcile high-performance functionality with environmental stewardship. Their inherent capacity for controlled degradation and biocompatibility has driven rapid advancements across electronics, sensing, actuation, and healthcare. In flexible electronics, these polymers serve as substrates, dielectrics, and conductive composites that enable transient devices, reducing electronic waste without compromising electrical performance. Within sensing and actuation, biodegradable polymer matrices facilitate the development of fully resorbable biosensors and soft actuators. These systems harness tailored degradation kinetics to achieve temporal control over signal transduction and mechanical response, unlocking applications in in vivo monitoring and on-demand drug delivery. In healthcare, biodegradable polymers underpin novel approaches in tissue engineering, wound healing, and bioresorbable implants. Their tunable chemical architectures and processing versatility allow for precise regulation of mechanical properties, degradation rates, and therapeutic payloads, fostering seamless integration with biological environments. The convergence of these emerging applications underscores the pivotal role of biodegradable polymers in advancing sustainable technology and personalized medicine. Continued interdisciplinary research into polymer design, processing strategies, and integration techniques will accelerate commercialization and broaden the impact of these lower eCO₂ value materials across diverse sectors. This perspective article comments on the innovation in these sectors that go beyond the applications of biodegradable materials in packaging applications. Full article

Polymer network-based nanogels (NGs) and microgels (MGs) have emerged as highly versatile platforms for advanced drug delivery, owing to their tunable architecture, biocompatibility, and responsiveness to diverse stimuli. This review presents a comprehensive and structured analysis of NG/MGs, encompassing their classification based on polymer origin, crosslinking mechanisms, composition, charge, stimuli-responsiveness, and structural architecture. We detail synthesis strategies—including inverse microemulsion and radiation-induced polymerization—and highlight key characterization techniques essential for evaluating physicochemical and functional properties. Emphasis is placed on the design-driven applications of NG/MGs in overcoming biological barriers and enabling targeted therapies, particularly in cancer, inflammation, diabetes, and viral infections. Multifunctional NGs integrating therapeutic and diagnostic capabilities (theranostics), as well as emerging platforms for immunotherapy and personalized medicine, are critically discussed. Finally, we address translational challenges and future directions, including scalable manufacturing, regulatory considerations, and integration with smart diagnostics. This review aims to serve as a foundational resource for researchers and clinicians developing next-generation NG/MG-based therapeutics. Full article

Functional hydrogels are a growing class of soft materials. Functional hydrogels are characterized by their three-dimensional (3D) polymeric network and high water-retention capacity. Functional hydrogels are deliberately engineered with specific chemical groups, stimuli-responsive motifs, or crosslinking strategies that impart targeted biomedical or environmental roles (e.g., drug delivery, pollutant removal). Their capacity to imitate the extracellular matrix, and their biocompatibility and customizable physicochemical properties make them highly suitable for biomedical and environmental applications. In contrast, non-functional hydrogels are defined as passive polymer networks that primarily serve as water-swollen matrices without such application-oriented modifications. Recent progress includes stimuli-responsive hydrogel designs. Stimuli such as pH, temperature, enzymes, light, etc., enable controlled drug delivery and targeted therapy. Moreover, hydrogels have shown great potential in tissue engineering and regenerative medicine. The flexibility and biofunctionality of hydrogels improve cell adhesion and tissue integration. Functional hydrogels are being explored for water purification by heavy metal ion removal and pollutant detection. The surface functionalities of hydrogels have shown selective binding and adsorption, along with porous structures that make them effective for environmental remediation. However, hydrogels have long been postulated as potential candidates to be used in clinical advancements. The first reported clinical trial was in the 1980s; however, their exploration in the last two decades has still struggled to achieve positive results. In this review, we discuss the rational hydrogel designs, synthesis techniques, application-specific performance, and the hydrogel-based materials being used in ongoing clinical trials (FDA–approved) and their mechanism of action. We also elaborate on the key challenges remaining, such as biocompatibility, mechanical stability, scalability, and future directions, to unlocking their multifunctionality and responsiveness. Full article

Nisin, a food preservative lantibiotic produced by Lactococcus lactis, exhibits potent antimicrobial activity against a wide range of Gram-positive pathogens, including antibiotic-resistant strains such as methicillin-resistant Staphylococcus aureus (MRSA). This study explores the development of a novel nano drug delivery platform comprising nisin-loaded niosomes, formulated via microfluidic mixing, and integrated into fast-dissolving oral films for targeted buccal administration. Microfluidic synthesis enabled the precise control of critical parameters including the flow rate ratio, surfactant composition, and lipid concentration, resulting in uniform niosomal vesicles with optimal size distribution (100–200 nm), low polydispersity index, and high encapsulation efficiency. Span 40 and Span 60 were employed as non-ionic surfactants, stabilized with cholesterol to improve bilayer rigidity and drug retention. The encapsulated nisin demonstrated improved physicochemical stability over time and protection against proteolytic degradation, thus preserving its antimicrobial potency. The niosomal suspensions were subsequently incorporated into polymer-based oral films as a final dosage form composed of polyvinyl alcohol (PVA) as the primary film-forming polymer, polyethylene glycol 400 (PEG400) as a plasticizer, and sucralose and mint as a sweetener and flavoring agent, respectively. A disintegrant was added to accelerate film dissolution in the oral cavity, facilitating the rapid release of niosomal nisin. The films were cast and evaluated for thickness uniformity, mechanical properties, disintegration time, surface morphology, and drug content uniformity. The dried films exhibited desirable flexibility, rapid disintegration (<30 s), and consistent distribution of nisin-loaded vesicles. In vitro antimicrobial assays confirmed that the bioactivity of nisin was retained post-formulation, showing effective inhibition zones (16 mm) against Bacillus subtilis. This delivery system offers a promising platform for localized antimicrobial therapy in the oral cavity, potentially aiding in the treatment of dental plaque, oral infections, and periodontal diseases. Overall, the integration of microfluidic-synthesized nisin niosomes into oral films presents a novel, non-invasive strategy for enhancing the stability and therapeutic efficacy of peptide-based drugs in mucosal environments. Physicochemical characterization of the niosomes and niosome films was performed using Fourier-transform infrared spectroscopy (FTIR), differential scanning calorimetry (DSC) and thermogravimetric analysis (TGA) to evaluate thermal stability and scanning electron microscopy (SEM) to assess surface morphology. In vitro peptide release studies demonstrated sustained release from both niosomal suspensions and film matrices, and the resulting data were further fitted to established kinetic models to elucidate the underlying drug release mechanisms. This delivery system offers a promising platform for localized antimicrobial therapy in the oral cavity, potentially aiding in the treatment of dental plaque, oral infections, and periodontal diseases. Overall, the integration of microfluidic-synthesized nisin niosomes into oral films presents a novel, non-invasive strategy for enhancing the stability and therapeutic efficacy of peptide-based drugs in mucosal environments. Full article

Silver nanoparticles (AgNPs) have garnered significant attention due to their potent antimicrobial properties and broad-spectrum efficacy against pathogens. Recent advances in polymer science have enabled the development of AgNPs-integrated hydrogels and membranes, offering multifunctional platforms for biomedical and food-related applications. This review provides a comprehensive overview of recent strategies for synthesizing and incorporating AgNPs into polymeric matrices, highlighting both natural and synthetic polymers as carriers. The structural and functional properties of these nanocomposite systems, such as biocompatibility, mechanical stability, controlled silver ion release, and antimicrobial activity, are critically examined. The focus is placed on their application in wound healing, drug delivery, food packaging, and preservation technologies. Challenges such as cytotoxicity, long-term stability, and regulatory concerns are discussed alongside emerging trends and safety paradigms. This work underscores the potential of AgNPs–polymer hybrids as next-generation materials and outlines future directions for their sustainable and targeted application in biomedical and food systems. Full article